Skip to content

Acupuncture in the Diagnosis and Treatment of Parkinson's Disease-A Prospective Randomized Controlled Clinical Study Protocol

Acupuncture in the Diagnosis and Treatment of Parkinson's Disease-A Prospective Randomized Controlled Clinical Study Protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000402
Enrollment
Unknown
Registered
2025-02-24
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Acupuncture group:Basic drug therapy + acupuncture treatment
Waiting for treatment group:Basic drug therapy
sham acupuncture group:Basic drug therapy + sham acupuncture treatment

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for Parkinson's disease in Western medicine; (2) Aged between 25 and 80 years; (3) Hoehn-Yahr stage within 1-4; (4) Conscious, stable vital signs, no significant intellectual disability, no significant hearing impairment; (5) Those who have signed an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Parkinson's syndrome caused by various etiologies such as cerebrovascular disease and poisoning, progressive supranuclear palsy, multiple system atrophy, Lewy body dementia, and corticobasal degeneration, etc.; (2) Individuals with significant medical conditions, such as severe liver or kidney disease, blood disorders, tumors, endocrine diseases, or pain syndromes; (3) Those concurrently participating in other drug or acupuncture clinical trials; (4) Patients with mental illness; (5) Individuals with hearing loss or communication difficulties; (6) People with a history of alcoholism or substance abuse; (7) Pregnant or planning-to-be-pregnant women.

Design outcomes

Primary

MeasureTime frame
Unified Parkinson's Disease Rating Scale;

Secondary

MeasureTime frame
Neuromelanin sensitive MRI;Parkinson's Disease Non-Motor Symptom Evaluation Scale;39-item Quality of Daily Living Scale for Parkinson's Disease;Quantitative analysis of the Synapsys Human Postural Balance System;Diffusion tensor imaging;Magnetic sensitive imaging;Resting-state fMRI;Multi-parameter quantitative magnetic resonance;Shear wave elastography;

Countries

China

Contacts

Public ContactNanbu Wang

State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Affiliated Hospital of Guangzhou University of Chinese Medicine

nanbuwang@gzucm.edu.cn13903063126

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 15, 2026